Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Depreciation & Amortization (CF) data on record, last reported at $12.9 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 11.38% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $50.7 million, up 30.21%, while the annual FY2025 figure was $45.6 million, 26.06% up from the prior year.
  • Depreciation & Amortization (CF) reached $12.9 million in Q4 2025 per PAHC's latest filing, roughly flat from $12.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $12.9 million in Q4 2025 and bottomed at -$24.0 million in Q2 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $7.9 million, with a median of $8.7 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): decreased 4.0% in 2021, then soared 134.97% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $8.0 million in 2021, then grew by 6.22% to $8.5 million in 2022, then grew by 4.84% to $8.9 million in 2023, then rose by 29.9% to $11.6 million in 2024, then increased by 11.38% to $12.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $12.9 million in Q4 2025, $12.8 million in Q3 2025, and $12.4 million in Q2 2025.